17.06.2015 - Shares of Pharmerica will continue to rise

The stock price of Pharmerica after declining within the channel has reached its lower boundary and the level of 31.00 and then renewed growth. According to our estimates, quotes are likely to continue the upward movement of the price to the level of 33.90 in the near future. Overcoming this level will be a signal for continued growth with targets at 35.00 and 36.50. A signal to sell will be fixing below 31,00. We expect growth of quotations and recommend to open long positions after the buy signal.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.